ARTICLE
2 February 2022

Ken Davis Discusses Future Use Of Artificial Intelligence In Health Care

KM
Katten Muchin Rosenman LLP

Contributor

Katten is a firm of first choice for clients seeking sophisticated, high-value legal services globally. Our nationally and internationally recognized practices include corporate, financial markets and funds, insolvency and restructuring, intellectual property, litigation, real estate, structured finance and securitization, transactional tax planning, private credit and private wealth.
Health Care partner Ken Davis spoke with Reuters Legal News in a video interview coinciding with the approval of Medicare coverage for an autonomous artificial intelligence (AI)...
United States Food, Drugs, Healthcare, Life Sciences
Katten Muchin Rosenman LLP’s articles from Katten Muchin Rosenman LLP are most popular:
  • with Finance and Tax Executives
  • with readers working within the Business & Consumer Services industries

Health Care partner  Ken Davis spoke with Reuters Legal News  in a video interview coinciding with the approval of Medicare coverage for an autonomous artificial intelligence (AI) diagnostic system designed to detect a diabetic eye disease.

Medicare coverage of AI-based detection of diabetic retinopathy marks the first time that the Centers for Medicare & Medicaid Services has allowed reimbursement for an autonomous AI service. It also comes at a time when the use of AI continues to expand in the health care industry and health care organizations work to address several potential issues, such as data privacy and general liability.

Ken explained that AI eventually might become so deeply rooted in the health care system that patients could start to question doctors for not using the technology. For instance, Ken noted that it is conceivable that doctors could face future negligence claims for failing to use AI.

"What you may start seeing over the course of time is the standard of care will evolve so that it will be that you must use AI."

https://www.reuters.com/video/watch/idRCV00AONI?utm_term=

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More